Products & Reviews

Sino Biological provides an extensive range of premium products supporting organoid culture, differentiation, analysis, and identification.

Sino Biological can produce highly efficient antibodies in HEK293 and CHO cells in as fast as 2 weeks with 1,000+ Antibodies per batch.

Sino Biological recently launched a Research Highlights series to discuss the latest biomedical advancements and how our exclusive bioreagent products drive scientific breakthroughs. Our engaging and informative content bridges innovation and application, empowering you to make remarkable contributions to your field.

Sino Biological provides a wide range of influenza virus research reagents and technical services, supporting vaccine safety and immunogenicity assessment and vaccine protective efficacy evaluation.

Sino Biological has successfully developed a series of GMP-grade cytokines using the GMP-grade quality management system, which utilizes superior quality management and release testing criteria.

Sino Biological offers a wide range of products and services to provide customers with complete multispecific antibody development solutions covering various phases of the development process, such as antibody development and optimization, druggability assessment, animal model evaluation, and process development.

Sino Biological provides comprehensive solutions for CAR-T cell therapy companies from CAR development, T cell activation, lentivirus packaging, CAR-T cell expansion to CAR-T cell quality control, fully supporting CAR-T research.

Sino Biological has developed a series of high-quality research reagents for dominant SARS-CoV-2 mutants, including recombinant antigens, detection antibodies, ELISA kits, pseudovirus, cDNAs, peptide pools, and receptor ACE2. These variant reagents have actively supported the basic research of SARS-CoV-2 and the development of vaccines, therapeutic antibodies, and diagnostic reagents.

Owing to the importance of in vitro screening and target validation during the early stages of antibody discovery, Sino Biological has established in vitro activity assay platforms for streamlining antibody drug development projects.

Sino Biological provides comprehensive reagents and services for CAR-NK cell therapy development to support our customers from early target discovery to the preclinical phase of research and development.

Sino Biological offers a comprehensive array of recombinant cytokines tailored for cell culture to advance research in tumor immunotherapy, stem cell therapy, drug screening, and regenerative medicine. With stringent quality control and extensive validation, we guarantee that our cytokines have high purity, validated biological activity, high stability, and low endotoxin levels.

Sino Biological offers a series of high-quality cytokines with high activity, low endotoxin, high batch-to-batch consistency, and high purity. These cytokines support various applications, including immune cell culture, immune cell therapy, drug development, and vaccine research.

Cytokines play a pivotal role in stem cell renewal and differentiation. To support stem cell research, Sino Biological offers a wide range of high-quality and GMP-grade recombinant cytokines with high bioactivity, high lot-to-lot consistency, and high purity.

Cytokines and their receptors show great potential in tumor immunotherapy, and many cytokines have been identified as targets for tumor drug development. Sino Biological's cytokines support stem cells, neural cells, immune cells, and organoids, facilitating functional studies and accelerating scientific discoveries.

Sino Biological has developed an extensive suite of recombinant complement proteins, covering C1s, C2, C3, C5, C7, Factor B, D, H, I and more, advancing the development of novel treatments targeting complement proteins.

Sino Biological offers a comprehensive range of recombinant HER3 proteins and antibodies, facilitating studies on HER3 signaling, protein-protein interactions, and drug efficacy assessments.

Sino Biological provides a comprehensive range of recombinant CEACAM proteins and corresponding CEACAM antibodies for crucial research, aiding investigations into CEACAM interactions with pathogens and their potential in new medical discoveries.

The Beacon® single-cell optofluidic system can be used to accurately select single cells on a chip, perform multiple single-cell assays, and export target cells based on specific results. The Beacon® optofluidic platform preserves the diversity of B cells, generating high-quality positive hits at an early stage of discovery and avoiding the loss of “good clones”.